Dr. Indira Muzib Yallamalli is a distinguished pharmaceutical scientist with expertise in the design and development of advanced drug delivery systems. She is currently working at the Institute of Pharmaceutical Technology, Sri Padmavati Mahila Visvavidyalayam (Women’s University), where she has dedicated 28 years to teaching and 26 years to research. She has extensively contributed to the field through research on nanocarriers, including carbon nanotubes, nanosponges, cubosomes, nanoparticles, transdermal and targeted drug delivery systems focusing on colon and brain therapeutics. Her research also covers herbal formulations and pharmacokinetic/pharmacodynamic studies.
Dr. Yallamalli earned recognition early in her academic journey by receiving the Junior Research Fellowship (JRF) from the University Grants Commission (UGC) during her Master’s program (1994–1996). Over the years, she has been actively engaged in academia, mentoring more than 14 Ph.D. scholars (completed) and guiding numerous M.Pharm (52) and B.Pharm (20) students. Her contribution to educational growth extends to organizing and participating in workshops, conferences, and webinars at both national and international levels.
Research Contributions
-
Research Grants: Secured PM USHA research grants totaling ₹13 lakhs across two projects.
-
Patents: Filed 1, with 3 granted; additionally, 4 patents have been published.
-
Publications: Authored 75 peer-reviewed publications, garnering 705 citations, with an h-index of 16 and an i10-index of 19.
-
Guidance & Mentoring: Supervised and trained over 86 students in pharmaceutical research.
-
Conferences & Workshops: Organized 15 national and international events and presented in over 40 forums, enriching global pharmaceutical discourse.
Research Excellence & Selected Publications
Dr. Yallamalli’s work on nanoparticle-mediated drug delivery, brain targeting, and transdermal systems has been widely recognized. Selected publications include:
-
Enhanced in vitro and in vivo kinetics using SLNs for transdermal delivery of furosemide (2017).
-
Oral delivery of low molecular weight heparin through novel nanoparticles (2017).
-
Selegiline-loaded chitosan nanoparticles for Parkinson’s disease management (2018).
-
Brain-targeted lamotrigine in-situ gel formulation (2023).
-
Pulmonary delivery systems for posaconazole optimized via quality-by-design approaches (2024).
She has also explored natural-resource-based formulations, such as colon-targeted drug delivery using guar gum and bamboo seed oil extracts.
Awards & Fellowships
-
JRF from UGC (1994–1996) during postgraduate studies.
-
Asia Pacific’s Who’s Who (2019).
-
International Education Excellence Award in Pharmaceutics (2021).
-
University Appreciation Award (2024).
-
International Best Research Award by Asia Research Award (2024).
-
International Star Research Award (2024).
-
NPTEL SPOC Local Chapter Coordinator Appreciation by IIT Madras (2024).
Eligibility for Nobel Professor Award
With a consistent record of groundbreaking research, innovative drug delivery system development, and contributions to pharmaceutical education, Dr. Indira Muzib Yallamalli is a prime candidate for the Nobel Professor Award in Scientific Laurels. Her commitment to advancing healthcare solutions, mentoring future scientists, and influencing global research initiatives aligns with the core values of this prestigious recognition.